These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 309400)

  • 21. H-2K/H-2D and Mls and I region-associated antigens stimulate helper factor(s) involved in the generation of cytotoxic T lymphocytes.
    Scott JW; Ponzio NM; Orosz CG; Finke JH
    J Immunol; 1980 May; 124(5):2378-83. PubMed ID: 6444971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Failure of T cells specific for strong histocompatibility antigens to cooperate with B cells for a humoral response.
    Dennert G; De Rose M; Allen RS
    Eur J Immunol; 1977 Jul; 7(7):487-92. PubMed ID: 70364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of cytotoxic T cells specific for minor histocompatibility antigens by cross challenge in vitro with H-2 disparate adherent cells.
    Pilarski LM; Carayanniotis G
    J Immunol; 1985 Dec; 135(6):3686-90. PubMed ID: 2415580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor cell destruction by cytotoxic T lymphocytes: the basis of reduced antitumor cell activity in syngeneic hosts.
    Fishelson Z; Berke G
    J Immunol; 1981 May; 126(5):2048-52. PubMed ID: 6783702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NK 1+ CD4- CD8- alphabeta T cells in the peritoneal cavity: specific T cell receptor-mediated cytotoxicity and selective IFN-gamma production against B cell leukemia and myeloma cells.
    Sugie T; Kubota H; Sato M; Nakamura E; Imamura M; Minato N
    J Immunol; 1996 Nov; 157(9):3925-35. PubMed ID: 8892624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-mediated lympholytic responses against autologous cells modified with haptenic sulfhydryl reagents. V. H-2Ld self products are recognized by anti-AED-specific cytotoxic T cells.
    Levy RB; Shearer GM
    J Immunol; 1983 Apr; 130(4):1506-11. PubMed ID: 6187809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance of metastatic tumor variants to tumor-specific cytotoxic T-lymphocytes not due to defects in expression of restricting major histocompatibility complex molecules in murine cells.
    Altevogt P; Leidig S; Heckl-Oestreicher B
    Cancer Res; 1984 Nov; 44(11):5305-13. PubMed ID: 6333273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Periodic loss of reactivity of a myeloma tumor with cytotoxic thymus-derived lymphocytes.
    Russell JH; Hale AH; Ginns LC; Eisen HN
    Proc Natl Acad Sci U S A; 1978 Jan; 75(1):441-5. PubMed ID: 75547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of hapten epitope structure and hapten-self conjugation pattern on T cell specificity and Ir gene control in hapten-self cytotoxic and helper T cell responses.
    Takai Y; Mizuochi T; Fujiwara H; Hamaoka T
    J Immunol; 1984 Jan; 132(1):57-62. PubMed ID: 6197460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MIs locus recognition by a cloned line of H-2-restricted influenza virus-specific cytotoxic T lymphocytes.
    Braciale VL; Braciale TJ
    J Immunol; 1981 Sep; 127(3):859-62. PubMed ID: 6455473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retinoic acid stimulation of the induction of mouse killer T-cells in allogeneic and syngeneic systems.
    Dennert G; Crowley C; Kouba J; Lotan R
    J Natl Cancer Inst; 1979 Jan; 62(1):89-94. PubMed ID: 309967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses.
    Abrams SI; Stanziale SF; Lunin SD; Zaremba S; Schlom J
    Eur J Immunol; 1996 Feb; 26(2):435-43. PubMed ID: 8617315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro induction of tumor-specific immunity. III. Lack of requirement for H-2 compatibility in lysis of tumor targets by T cells activated in vitro to oncofetal and plasmacytoma antigens.
    Burton RC; Chism SE; Warner NL
    J Immunol; 1977 Mar; 118(3):971-80. PubMed ID: 300394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lysis of enucleated tumor cells with allogeneic and syngeneic cytotoxic thymus-derived lymphocytes.
    Hale AH; Paulus LK
    Eur J Immunol; 1979 Aug; 9(8):640-6. PubMed ID: 227696
    [No Abstract]   [Full Text] [Related]  

  • 35. Different phenotypic variants of the mouse B cell tumor A20/2J are selected by antigen- and mitogen-triggered cytotoxicity of L3T4-positive, I-A-restricted T cell clones.
    Jones B; Tite JP; Janeway CA
    J Immunol; 1986 Jan; 136(1):348-56. PubMed ID: 2415625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of primary cytotoxic T lymphocyte responses generated during mixed leukocyte culture with H-2d identical Qa-1-disparate cells.
    Huston DP; Tavana G; Rich RR; Gressens SE
    J Immunol; 1986 Sep; 137(6):1776-81. PubMed ID: 2943800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The H-2 phenotype of the thymus dictates the self-specificity expressed by thymic but not splenic cytotoxic T lymphocyte precursors in thymus-engrafted nude mice.
    Kruisbeek AM; Sharrow SO; Mathieson BJ; Singer A
    J Immunol; 1981 Nov; 127(5):2168-76. PubMed ID: 6975310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Some characteristics of the cyclophosphamide-induced immunopotentiating cells in the spleen of mice bearing a large MOPC-315 tumor.
    Mokyr MB; Ye QW
    Cancer Res; 1985 Oct; 45(10):4932-9. PubMed ID: 4027979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes.
    Fan J; Bonavida B
    J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. I. Isolation of a selectively resistant variant tumor subclone.
    Green WR
    Eur J Immunol; 1983 Nov; 13(11):863-70. PubMed ID: 6196206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.